UBS AM’s HOOKIPA Pharma HOOK Stock Holding History

UBS AM’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-32,040	Closed	-$1.89M	–	2875
2021 Q3	$1.89M	Sell	32,040 -1,081	-3%	-$78.4K	﹤0.01%	1866
2021 Q2	$3.03M	Buy	+33,121	New	+$4.42M	﹤0.01%	1655

Other funds holding HOOK

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM's HOOK Position: Q4 2021 in Review

UBS AM sold out of HOOKIPA Pharma (HOOK) in Q4 2021, closing a stake of 32,040 shares — an estimated $1.89M sold.

UBS AM first reported a position in HOOK in Q2 2021 and held it in 2 quarters. The position peaked at $3.03M in Q2 2021. 72 funds tracked by Wall St. Rank hold HOOK as of Q4 2021.

UBS AM reported no remaining HOOKIPA Pharma position as of Q4 2021 after selling out during the quarter.
UBS AM sold 32,040 HOOKIPA Pharma shares in Q4 2021, an estimated $1.89M.
UBS AM first reported a position in HOOKIPA Pharma in Q2 2021 and held it in 2 quarters.
UBS AM's HOOKIPA Pharma position peaked at $3.03M in Q2 2021.
72 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2021.

Based on UBS AM's 13F filing for Q4 2021, filed 14 Feb 2022.